Company intelligence / Profile preview

Nuvothora

Fort Worth, Texas, United States

Ownership: Private
Development stage: Other

Overview

Nuvothera is a dermatology-focused biotechnology company that develops advanced topical treatments for chronic skin conditions. The company's primary offering is Prosoria, a comprehensive, multi-step treatment system designed to manage the symptoms of psoriasis and improve skin health using a combination of botanical ingredients and clinical-strength actives. Nuvothera's approach integrates pharmaceutical rigor with natural ingredients to provide safe and effective long-term solutions for patients. Founded by dermatology industry experts, the company is based in Fort Worth, Texas.

Therapeutic areas: Dermatology
Modalities: Small moleculeTopicalBotanical extracts
Industry: Biotech

Beyond the preview

Go deeper on Nuvothora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuvothora.

Explore the full profile